🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12554+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12554 recruiting trials

NARecruitingNCT06468696

Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients

👨‍⚕️ Zhidong Wang, Xi'an Jiaotong University Second Affiliated Hospital📍 1 site📅 Started Apr 2023View details ↗
NARecruitingNCT06347640

Outcome of Pulp Revascularization of Necrotic Mature Permanent Teeth Using Platelet-rich Fibrin

👨‍⚕️ Lama Awawdeh, Jordan University of Science and Technology📍 1 site📅 Started Apr 2023View details ↗
NARecruitingNCT06666634

Validation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy

🏥 The Netherlands Cancer Institute📍 1 site📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT05941325

A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma

🏥 Shanghai 6th People's Hospital📍 1 site📅 Started Apr 2023View details ↗
NARecruitingNCT05720078

UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)

🏥 Sunnybrook Health Sciences Centre📍 1 site📅 Started Apr 2023View details ↗
Phase 1RecruitingNCT05450744

131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)

🏥 Telix Pharmaceuticals (Innovations) Pty Limited📍 6 sites📅 Started Apr 2023View details ↗
NARecruitingNCT05695885

STEPS Implementation Trial

🏥 University of Alabama, Tuscaloosa📍 1 site📅 Started Apr 2023View details ↗
RecruitingNCT06071377

Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)

👨‍⚕️ Julie Kanter, MD, National Alliance for Sickle Cell Centers📍 10 sites📅 Started Apr 2023View details ↗
RecruitingNCT05967949

A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.

🏥 The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Apr 2023View details ↗
RecruitingNCT06715267

Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)

🏥 University Hospital, Brest📍 1 site📅 Started Apr 2023View details ↗
RecruitingNCT06946563

Fetoscopic Neural Tube Defect Repair

👨‍⚕️ Raphael Sun, MD, Oregon Health and Science University📍 1 site📅 Started Apr 2023View details ↗
RecruitingNCT05887011

CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia

🏥 AstraZeneca📍 41 sites📅 Started Mar 2023View details ↗
Phase 3RecruitingNCT05328258

Use of GnRHa During Chemotherapy for Fertility Protection

🏥 Kenny Rodriguez-Wallberg📍 17 sites📅 Started Mar 2023View details ↗
RecruitingNCT04685200

Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach

👨‍⚕️ Theo Heller, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)📍 1 site📅 Started Mar 2023View details ↗
RecruitingNCT05779813

Genetic Frontotemporal Dementia Initiative for Neurodevelopment

👨‍⚕️ Elizabeth Finger, MD, Western University📍 1 site📅 Started Mar 2023View details ↗
Phase 1, PHASE2RecruitingNCT05608681

A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).

👨‍⚕️ Mark Kowalski, MD PhD, Eupraxia Pharmaceuticals📍 23 sites📅 Started Mar 2023View details ↗
NARecruitingNCT07366099

Al18F-NOTA-LM3 PET/CT in Patients With TIO

🏥 Peking Union Medical College Hospital📍 1 site📅 Started Mar 2023View details ↗
EARLY_Phase 1RecruitingNCT06061614

Safety and Efficacy Study of NGGT002 in PKU Adult Subjects

👨‍⚕️ Huan Zhou, Doctor📍 1 site📅 Started Mar 2023View details ↗
NARecruitingNCT05793008

Characterization of priMary And sEcondary STress Related takOtsubo

👨‍⚕️ Rocco A Montone, MD, PhD, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Mar 2023View details ↗
Phase 1RecruitingNCT05759793

A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

🏥 Nanjing IASO Biotechnology Co., Ltd.📍 1 site📅 Started Mar 2023View details ↗
← PreviousPage 418 of 628Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →